Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101941900A reveals a novel Ru-catalyzed asymmetric hydrogenation route for high-purity chiral acids, offering significant cost reduction in API manufacturing and enhanced supply chain stability.
Patent CN111875577B details a one-pot synthesis of high-purity R-propylene carbonate using recyclable S-salen Co(II), offering significant cost and waste reduction for API manufacturers.
Discover the novel Ir-catalyzed asymmetric synthesis of colchicine from isovanillin. A cost-effective, scalable route for high-purity pharmaceutical intermediates.
Novel ruthenium catalyst method for ceramide intermediates. High stereoselectivity and reduced reaction time for supply chain efficiency.
Patent CN111203276B reveals a manganese-catalyzed hydrosilylation method for high-purity chiral silanes, offering significant cost reduction and supply chain stability for pharmaceutical intermediates.
Patent CN107382874A details high-yield synthesis of chiral NHC salts. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Novel Ru-BINAP catalyzed route for (R)-5'-methoxylaudanosine. High purity >99.98% ee, non-genotoxic process, scalable for Mivacurium Chloride production.
Patent CN107552089A reveals low-cost squaramide catalyst for high-purity tetrahydro-beta-carboline derivatives ensuring supply chain stability.
Patent CN113666915B reveals a novel 5-step route for posaconazole intermediates using chiral iron catalysis, offering high purity and scalable manufacturing for global supply chains.
Patent CN110872232B reveals a novel phase transfer catalysis method for synthesizing chiral alpha-difluoromethyl-beta-keto esters, offering significant cost reduction and scalability for API manufacturing.
Novel water-phase catalytic method enhances yield and ee for chiral intermediates. Reduces costs and improves supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN102675415B details a novel copper-catalyzed route for bortezomib intermediates, offering enhanced scalability and cost efficiency for API manufacturing.
Patent CN109265385A reveals a one-pot synthesis for high-purity chiral diphenylprolinol. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN102076634A details enantioselective hydrogenation of N-H imines. Discover cost-effective routes for high-purity pharmaceutical intermediates without protection steps.
Novel Rh-catalyzed asymmetric hydrogenation route for Pramipexole. Higher yield, lower cost, industrial scale ready. Ideal for pharma intermediates.
Patent CN102249976B discloses a scalable route to (-)-clausenamide using fructose-derived catalysts, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN101029049B reveals a breakthrough in recyclable cinchona alkaloid ligands for synthesizing paclitaxel and docetaxel side chains, offering significant cost reduction and supply chain stability.
Patent CN101029049B reveals a breakthrough in recyclable cinchona alkaloid ligands for paclitaxel synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN105330554B reveals a safer synthesis for Efavirenz intermediates. Achieve high ee values and cost reduction in API manufacturing with scalable zinc chemistry.
Patent CN1215028C details a supramolecular optical resolution method for racemic diphenols using pyroglutamic acid derivatives, offering high efficiency and reagent recovery for chiral ligand manufacturing.